Pratik Sandesara, MD
Interventional Cardiology · Atlanta, GANPI 1033452354
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $103,746 of the $165,128 with a category attached, or 62.8%. 19 manufacturers reported payments, led by Boston Scientific at 52.0% of the total. 2025 is the largest year on record at $114,471, more than ten times the $3,315 reported in 2021. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 487 payments — averaging $339.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$86K
- Penumbra, Inc.$32K
- Medtronic$16K
- Asahi Intecc USA, Inc.$11K
- Abbott$9K
- Abiomed$5K
- plus $7K from 13 others
Across 19 payments — averaging $10,627 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$114K
- Shockwave Medical, Inc$53K
- Arrow International, Inc.$35K
What the payments were for
- Consulting fees$4,7383%
- Speaking & faculty fees$103,74663%
- Travel & lodging$31,36019%
- Food & beverage$25,21215%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 163 | $85,845 |
| Penumbra, Inc. | 57 | $32,419 |
| Medtronic | 96 | $15,590 |
| Asahi Intecc USA, Inc. | 37 | $10,535 |
| Abbott | 42 | $9,059 |
| Abiomed | 27 | $4,538 |
| Inari Medical, Inc. | 11 | $1,982 |
| Shockwave Medical, Inc | 17 | $1,350 |
| Edwards Lifesciences | 5 | $910 |
| W. L. Gore & Associates, Inc. | 11 | $789 |
| Heartflow, Inc. | 2 | $683 |
| Teleflex LLC | 4 | $468 |
| Cardiva Medical, Inc. | 3 | $274 |
| Philips North America LLC | 6 | $236 |
| Recor Medical Inc | 1 | $180 |
| Thrombolex, Inc. | 1 | $120 |
| Verge Medical, Inc. | 1 | $88 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Angiodynamics, Inc. | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL VASCULAR ACCESS$71,617
- Indigo System$31,533
- RESOLUTE ONYX$7,922
- PERIPHERAL VASCULAR$6,770
- ONYX FRONTIER$5,734
- DRAGONFLY OPSTAR$4,589
- Impella$3,636
- ASAHI PTCA Guide Wire$2,629
- GENERAL - THERAPIES$2,498
- XIENCE SKYPOINT$2,093
- FLOWTRIEVER CATHETER, S$1,953
- CT THROMBECTOMY SYSTEM KIT$1,743
- AVVIGO Guidance System$1,397
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,115
- FFRct$683
- ROTAPRO$677
- General - Balloon Catheters$625
- OPTIS$585
- OPTICROSS$527
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$508
How this compares
$165,128 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 94 | $91,668 |
| EntrestoSacubitril/Valsartan | 41 | $44,769 |
| FarxigaDapagliflozin Propanediol | 30 | $41,976 |
| BrilintaTicagrelor | 56 | $37,750 |
| JardianceEmpagliflozin | 24 | $21,888 |
| Repatha SureclickEvolocumab | 16 | $9,724 |
| ClopidogrelClopidogrel Bisulfate | 446 | $4,545 |
| Ranolazine ErRanolazine | 69 | $4,203 |
| Prasugrel Hcl | 32 | $2,151 |
| Atorvastatin Calcium | 199 | $1,810 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 133 | $1,661 |
| Metoprolol Succinate | 128 | $1,173 |
| Carvedilol | 91 | $636 |
| Rosuvastatin Calcium | 67 | $599 |
| Pantoprazole Sodium | 56 | $520 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Atlanta
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Adam GreenbaumAtlanta$238K
- Wissam JaberAtlanta$222K
- Katherine KunkelAtlanta$189K
- James StewartAtlanta$174K
- Chandanreddy DevireddyAtlanta$121K
- Prashant KaulAtlanta$109K
- Nikoloz ShekiladzeAtlanta$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.